Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Neuregulin and Notch Signalling Linked in Developing Brain
27 March 2003. The family of neuregulin-1 growth and differentiation factors is rapidly piquing the interest of researchers in areas ranging from schizophrenia to Alzheimer's disease. In the March 20 early online PNAS, Eva Anton, Ralf Schmid, and their colleagues at the University of North Carolina, Chapel Hill; Yale University in New Haven, Connecticut; and CeNes Pharmaceuticals in Norwood, Massachusetts, report that neuregulin-1 signaling involving the erbB2 receptor pathway-possibly in concert with Notch signaling-is critical for cellular differentiation that allows appropriate cortical development. This finding has no direct implications for the above diseases, but hints at possible connections to be explored.

The distinctive laminar structure of the mammalian neocortex is constructed in large part thanks to a scaffolding of radial glial cells that forms during development. As shown in pioneering work by Pasko Rakic of Yale and others, these cells are multi-talented: Their long fibers extending from the unfolding brain’s ventricles to its surface provide migrational paths and cues for newly born neurons to follow from germinal zones to their final destinations. Moreover, researchers including Gotz, Miyata, and Kriegstein have shown that radial glial cells are themselves progenitor cells. They can give rise to neurons and convert to astrocytes after embryogenesis, when a guiding scaffold is no longer needed.

One of the molecules expressed by both neurons and glial precursors in this developmental environment is neuregulin-1 (NRG-1), which affects cellular differentiation via the protein tyrosine kinase receptors erbB2, -B3, and -B4. Anton and coworkers sought to determine whether, and by what pathways, NRG-1 affects the development and differentiation of radial glial cells. Continuing earlier work, they found that the absence of NRG-1 in knockout mice reduced the number of radial glia generated by cultured embryonic neuroepithelial cells. The addition of exogenous NRG-1 to these cultures restored the production of radial glia.

Anton and colleagues also found evidence suggesting that NRG-1 is crucial not just for the development of radial glial cells, but also for the maintenance of the scaffold, and that the erbB2 receptor modulates this. In vitro, blocking erbB2 activity prevented the radial glia from assuming their characteristic shape; in vivo, interfering with erbB2 produced aberrant radial glial development, including their premature transformation into astrocytes.

Further experiments indicated that erbB2 mediates a dynamic balance between radial glial cells and astrocytes. For example, when erbB2 is reexpressed in mature astrocytes, the ratio of radial glia to astrocytes increases, indicating that NRG-1 signaling via erbB2 induced astrocytes to become radial glia.

The authors suggest that there might be reason to investigate the potential of the NRG-1-erbB2 pathway to induce neurogenesis in the adult brain. "Functional induction of erbB2 in mature astrocytes may facilitate their ability to support cell migration or neurogenesis during ongoing maintenance of neural circuitry in mature CNS," they write.

Of particular interest to Alzheimer’s researchers may be recent evidence that Notch signaling is critical for the development of radial glial cells. Notch and amyloid precursor protein are structurally similar and are both cleaved by γ-secretase to produce similar transcriptionally active intracellular domains (see ARF related news story). Other research indicated that γ-secretase cleaves erbB4 (see ARF related news story).

Earlier this year, researchers reported that NRG-1 and the erbB family of receptors continue to be expressed in aging human brain, but that the distribution of expression changes in AD and that erbB4 and NRG-1 are associated with neuritic plaques (Chaudhury et al. 2003). In mice doubly transgenic for AßPP and presenilin-1 mutations, both erbB2 and -B4, along with NRG-1, were associated with neuritic plaques. In their current paper, Anton and his colleagues found evidence that Notch signaling affects radial glial cell development by upregulating the expression of erbB2 and thereby increasing the response of radial glial cells to NRG signals. Neuregulin also recently emerged as a possible genetic risk factor for schizophrenia, a disease that is clearly distinct from AD, but shows some overlap in that AD patients can develop psychotic symptoms in later stages of the disease (Stefansson et al, 2002; Stefansson et al, 2003).-Hakon Heimer.

Reference:
Schmid RS, McGrath B, Berechid BE, Boyles B, Marchionni M, Sesta N, Anton ES. Neuregulin-1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc Natl Acad Sci U S A. 2003 Mar 20. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad